newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

LONDON, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that